RT Journal
A1 Kleckner MS, Jr.
T1 THerapy in the anemias
JF Journal of the American Medical Association
JO Journal of the American Medical Association
YR 1959
FD March 28
VO 169
IS 13
SP 1510
OP 1510
DO 10.1001/jama.1959.03000300106022
UL http://dx.doi.org/10.1001/jama.1959.03000300106022
AB To the Editor:— 
    In the June 7, 1958, issue of The Journal, page 735, an article entitled "Current Status of Therapy in Anemias," by Lichtman, states that parenterally administered iron, for example, in the form of an iron-dextran complex (Imferon) in great excesses over a long period of time will produce "exogenous hemochromatosis." Since parenteral therapy with properly calculated dosage of iron-dextran complex should be discontinued when a hematological response has been obtained, as well as when this type of therapy fails or the patient eventually becomes anemic, iron-storage diseases, i. e., hemosiderosis or hemochromatosis, should not occur under these circumstances, because the possibility of iron overload is eliminated. The subject of iron-overload has been discussed in a textbook, "Iron in Clinical Medicine" (edited by Wallerstein and Mettier, Berkeley, University of California Press, 1958). The question of whether hemosiderosis progresses to hemochromatosis has been answered both affirmatively and negatively. Much